Beat Mullhaupt
Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection.
Radu P, Becchetti C, Schropp J, Schmid P, Künzler-Heule P, Mertens J, Moradpour D, Mullhaupt B, Semela D, Negro F, Heim M, Clerc O, Roelens M, Keiser O, Berzigotti A, Swiss Hepatitis C Cohort Study. Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection. Cancers (Basel) 2024; 16
18.07.2024Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection.
18.07.2024Cancers (Basel) 2024; 16
Radu Pompilia, Becchetti Chiara, Schropp Jonas, Schmid Patrick, Künzler-Heule Patrizia, Mertens Joachim C, Moradpour Darius, Mullhaupt Beat, Semela David, Negro Francesco, Heim Markus H, Clerc Olivier F, Roelens Maroussia, Keiser Olivia, Berzigotti Annalisa, Swiss Hepatitis C Cohort Study
AXL expression on homeostatic resident liver macrophages is reduced in cirrhosis following GAS6 production by hepatic stellate cells.
Pop O, Geng A, Flint E, Singanayagam A, Ercan C, Possamai L, Patel V, Künzler-Heule P, Meier M, Soysal S, Hruz P, Kollmar O, Tatham K, Ward J, Mullhaupt B, Weber A, Wendon J, Niess J, Heim M, Semela D, Weston C, Antoniades C, Terracciano L, Triantafyllou E, Brenig R, Bernsmeier C. AXL expression on homeostatic resident liver macrophages is reduced in cirrhosis following GAS6 production by hepatic stellate cells. Cell Mol Gastroenterol Hepatol 2023
31.03.2023AXL expression on homeostatic resident liver macrophages is reduced in cirrhosis following GAS6 production by hepatic stellate cells.
31.03.2023Cell Mol Gastroenterol Hepatol 2023
Pop Oltin-Tiberiu, Geng Anne, Flint Emilio, Singanayagam Arjuna, Ercan Caner, Possamai Lucia A, Patel Vishal C, Künzler-Heule Patrizia, Meier Marie-Anne, Soysal Savas D, Hruz Petr, Kollmar Otto, Tatham Kate C, Ward Josie K, Mullhaupt Beat, Weber Achim, Wendon Julia, Niess Jan Hendrik, Heim Markus, Semela David, Weston Christopher J, Antoniades Charalambos G, Terracciano Luigi, Triantafyllou Evangelos, Brenig Robert, Bernsmeier Christine
HCV disease burden and population segments in Switzerland
Bihl F, Semmo N, Semela D, Scheidegger C, Razavi H, Negro F, Mullhaupt B, Lavanchy D, Dufour J, Castro Batänjer E, Bruggmann P, Blach S. HCV disease burden and population segments in Switzerland. Liver Int 2021
27.11.2021HCV disease burden and population segments in Switzerland
27.11.2021Liver Int 2021
Bihl Florian, Semmo Nasser, Semela David, Scheidegger Claude, Razavi Homie, Negro Francesco, Mullhaupt Beat, Lavanchy Daniel, Dufour Jean-François, Castro Batänjer Erika, Bruggmann Philip, Blach Sarah
Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue
Vieira Barbosa J, Moradpour D, Weber A, Lenggenhager D, Sempoux C, Mathurin P, Louvet A, Artru F, Gouttenoire J, Neuweiler J, Cathomas G, Montani M, Semela D, Filipowicz Sinnreich M, Brunner F, Mullhaupt B, Fraga M. Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue. Swiss Med Wkly 2021; 151:w20502.
04.05.2021Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue
04.05.2021Swiss Med Wkly 2021; 151:w20502
Vieira Barbosa Joana, Moradpour Darius, Weber Achim, Lenggenhager Daniela, Sempoux Christine, Mathurin Philippe, Louvet Alexandre, Artru Florent, Gouttenoire Jérôme, Neuweiler Jörg, Cathomas Gieri, Montani Matteo, Semela David, Filipowicz Sinnreich Magdalena, Brunner Felix, Mullhaupt Beat, Fraga Montserrat
Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland
Mullhaupt B, Semela D, Ruckstuhl L, Magenta L, Clerc O, Torgler R, Negro F, Semmo N. Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland. Swiss Med Wkly 2021; 151:w20399.
19.01.2021Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland
19.01.2021Swiss Med Wkly 2021; 151:w20399
Mullhaupt Beat, Semela David, Ruckstuhl Lisa, Magenta Lorenzo, Clerc Olivier, Torgler Ralph, Negro Francesco, Semmo Nasser
A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study
Semmo N, Mullhaupt B, Ruckstuhl L, Magenta L, Clerc O, Torgler R, Semela D. A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study. PloS one 2020; 15:e0241267.
04.11.2020A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study
04.11.2020PloS one 2020; 15:e0241267
Semmo Nasser, Mullhaupt Beat, Ruckstuhl Lisa, Magenta Lorenzo, Clerc Olivier, Torgler Ralph, Semela David
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
Roelens M, Keiser O, Negro F, Junker C, Semela D, Clerc O, Mullhaupt B, Schmid P, Semmo N, Cerny A, Moradpour D, Bertisch B, Swiss Hepatitis C Cohort Study. All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS). Open Forum Infect Dis 2020; 7:ofaa308.
25.07.2020All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
25.07.2020Open Forum Infect Dis 2020; 7:ofaa308
Roelens Maroussia, Keiser Olivia, Negro Francesco, Junker Christoph, Semela David, Clerc Olivier, Mullhaupt Beat, Schmid Patrick, Semmo Nasser, Cerny Andreas, Moradpour Darius, Bertisch Barbara, Swiss Hepatitis C Cohort Study
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections
Dietz J, Backhus J, Zizer E, Boettler T, Neumann-Haefelin C, Semela D, Stauber R, Berg T, Berg C, Zeuzem S, Vermehren J, Sarrazin C, Buggisch P, Matschenz K, Spengler U, Mullhaupt B, Schulze Zur Wiesch J, Piecha F, Mauss S, Seegers B, Hinrichsen H, Antoni C, Wietzke-Braun P, Peiffer K, Berger A, European HCV Resistance Study Group. Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections. Clin Gastroenterol Hepatol 2019
06.11.2019Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections
06.11.2019Clin Gastroenterol Hepatol 2019
Dietz Julia, Backhus Johanna, Zizer Eugen, Boettler Tobias, Neumann-Haefelin Christoph, Semela David, Stauber Rudolf, Berg Thomas, Berg Christoph, Zeuzem Stefan, Vermehren Johannes, Sarrazin Christoph, Buggisch Peter, Matschenz Katrin, Spengler Ulrich, Mullhaupt Beat, Schulze Zur Wiesch Julian, Piecha Felix, Mauss Stefan, Seegers Barbara, Hinrichsen Holger, Antoni Christoph, Wietzke-Braun Perdita, Peiffer Kai-Henrik, Berger Annemarie, European HCV Resistance Study Group
Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing
About F, Casanova J, Theodorou I, Sultanik P, Poynard T, Pol S, Bochud P, Cobat A, Abel L, Swiss Hepatitis C Cohort Study Group, Semmo N, Semela D, Bibert S, Jouanguy E, Nalpas B, Lorenzo L, Rattina V, Zarhrate M, Hanein S, Munteanu M, Mullhaupt B, French ANRS HC EP 26 Genoscan Study Group. Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing. Front Genet 2019; 10:1024.
04.11.2019Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing
04.11.2019Front Genet 2019; 10:1024
About Frédégonde, Casanova Jean-Laurent, Theodorou Ioannis, Sultanik Philippe, Poynard Thierry, Pol Stanislas, Bochud Pierre-Yves, Cobat Aurélie, Abel Laurent, Swiss Hepatitis C Cohort Study Group, Semmo Nasser, Semela David, Bibert Stéphanie, Jouanguy Emmanuelle, Nalpas Bertrand, Lorenzo Lazaro, Rattina Vimel, Zarhrate Mohammed, Hanein Sylvain, Munteanu Mona, Mullhaupt Beat, French ANRS HC EP 26 Genoscan Study Group
Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
Brezzi M, Keiser O, Negro F, Semela D, Mullhaupt B, Semmo N, Terziroli Beretta-Piccoli B, Moradpour D, Roelens M, Bertisch B, Swiss Hepatitis C Cohort Study. Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study. PloS one 2019; 14:e0218706.
24.06.2019Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
24.06.2019PloS one 2019; 14:e0218706
Brezzi Matteo, Keiser Olivia, Negro Francesco, Semela David, Mullhaupt Beat, Semmo Nasser, Terziroli Beretta-Piccoli Benedetta, Moradpour Darius, Roelens Maroussia, Bertisch Barbara, Swiss Hepatitis C Cohort Study
Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?
Bertisch B, Keiser O, Moradpour D, Zehnder C, Marinucci F, Roelens M, Moriggia A, Clerc O, Giudici F, Schmid P, Künzler-Heule P, Ottiger C, Mullhaupt B, Negro F, Brezzi M, Swiss Hepatitis C Cohort Study. Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?. Clin Infect Dis 2019
03.04.2019Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?
03.04.2019Clin Infect Dis 2019
Bertisch Barbara, Keiser Olivia, Moradpour Darius, Zehnder Cinzia, Marinucci Francesco, Roelens Maroussia, Moriggia Alberto, Clerc Olivier, Giudici Fabio, Schmid Patrick, Künzler-Heule Patrizia, Ottiger Cornelia, Mullhaupt Beat, Negro Francesco, Brezzi Matteo, Swiss Hepatitis C Cohort Study
Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions
Rusch U, Robbins S, Razavi H, Vernazza P, Blach S, Bruggmann P, Mullhaupt B, Negro F, Semela D. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions. Swiss Med Wkly 2019; 149:w14694.
23.01.2019Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions
23.01.2019Swiss Med Wkly 2019; 149:w14694
Rusch Urs, Robbins Sarah, Razavi Homie, Vernazza Pietro, Blach Sarah, Bruggmann Philip, Mullhaupt Beat, Negro Francesco, Semela David
Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
Mullhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Robbins Scott S, Semela D, Negro F. Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?. PloS one 2018; 13:e0209374.
31.12.2018Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
31.12.2018PloS one 2018; 13:e0209374
Mullhaupt Beat, Bruggmann Philip, Bihl Florian, Blach Sarah, Lavanchy Daniel, Razavi Homie, Robbins Scott Sarah, Semela David, Negro Francesco
Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study
Geier A, Mullhaupt B, Bischoff-Ferrari H, Saleh L, Marques Maggio E, Jahn D, Bantel H, Tschopp O, Seifert B, Tay F, Semela D, Stirnimann G, Eichinger M, Dufour J. Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study. Scand J Gastroenterol 2018:1-7.
29.09.2018Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study
29.09.2018Scand J Gastroenterol 2018:1-7
Geier Andreas, Mullhaupt Beat, Bischoff-Ferrari Heike A, Saleh Lanja, Marques Maggio Ewerton, Jahn Daniel, Bantel Heike, Tschopp Oliver, Seifert Burkhardt, Tay Fabian, Semela David, Stirnimann Guido, Eichinger Mareile, Dufour Jean-François
MRI and PET-CT Failed to Differentiate Between Hepatic Malignancy and Brucelloma
Schreiber P, Mullhaupt B, Schiesser M, Boggian K, Reiner C, Vrugt B, Kröger A, Fagagnini S, Schmid A, Günthard H. MRI and PET-CT Failed to Differentiate Between Hepatic Malignancy and Brucelloma. Open Forum Infect Dis 2018; 5:ofy052.
08.03.2018MRI and PET-CT Failed to Differentiate Between Hepatic Malignancy and Brucelloma
08.03.2018Open Forum Infect Dis 2018; 5:ofy052
Schreiber Peter W, Mullhaupt Beat, Schiesser Marc, Boggian Katia, Reiner Cäcilia S, Vrugt Bart, Kröger Arne, Fagagnini Stefania, Schmid Adrian, Günthard Huldrych F
Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Bachofner J, Mertens J, Terziroli Beretta-Piccoli B, Mullhaupt B, Magenta L, Semela D, Fehr J, Moncsek A, Seifert B, Braun D, Baserga A, Künzler-Heule P, Kröger A, Bergamin I, Valli P, The Swiss Hepatitis C Cohort Study. Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland. Swiss Med Wkly 2018; 148:w14560.
18.01.2018Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
18.01.2018Swiss Med Wkly 2018; 148:w14560
Bachofner Jacqueline, Mertens Joachim, Terziroli Beretta-Piccoli Benedetta, Mullhaupt Beat, Magenta Lorenzo, Semela David, Fehr Jan, Moncsek Anja, Seifert Burkhardt, Braun Dominique L, Baserga Adriana, Künzler-Heule Patrizia, Kröger Arne, Bergamin Irina, Valli Piero V, The Swiss Hepatitis C Cohort Study
Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030
Bruggmann P, Stoeckle M, Semela D, Schmid P, Razavi H, Rauch A, Mullhaupt B, Lavanchy D, Kouyos R, Fehr J, Deltenre P, Blach S, Negro F. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. Swiss Med Wkly 2017; 147:w14543.
09.11.2017Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030
09.11.2017Swiss Med Wkly 2017; 147:w14543
Bruggmann Philip, Stoeckle Marcel, Semela David, Schmid Patrick, Razavi Homie, Rauch Andri, Mullhaupt Beat, Lavanchy Daniel, Kouyos Roger, Fehr Jan, Deltenre Pierre, Blach Sarah, Negro Franco
Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland
Fraga M, Sahli R, Greub G, Telenti A, Aubert V, Terziroli Beretta-Piccoli B, Stickel F, Semela D, Ripellino P, Mullhaupt B, Brunner F, Bihl F, Moulin H, Doerig C, Moradpour D. Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland. Liver Int 2017
23.08.2017Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland
23.08.2017Liver Int 2017
Fraga Montserrat, Sahli Roland, Greub Gilbert, Telenti Amalio, Aubert Vincent, Terziroli Beretta-Piccoli Benedetta, Stickel Felix, Semela David, Ripellino Paolo, Mullhaupt Beat, Brunner Felix, Bihl Florian, Moulin Hervé, Doerig Christopher, Moradpour Darius
Visualization of hepatitis E virus RNA and proteins in the human liver
Lenggenhager D, Moradpour D, Sempoux C, Mullhaupt B, Rubbia-Brandt L, Terracciano L, Sahli R, Fraga M, Aepli P, Hürlimann S, Neuweiler J, Semela D, Kreutzer S, Honcharova-Biletska H, Bawohl M, Malehmir M, Gouttenoire J, Weber A. Visualization of hepatitis E virus RNA and proteins in the human liver. J Hepatol 2017; 67:471-479.
13.04.2017Visualization of hepatitis E virus RNA and proteins in the human liver
13.04.2017J Hepatol 2017; 67:471-479
Lenggenhager Daniela, Moradpour Darius, Sempoux Christine, Mullhaupt Beat, Rubbia-Brandt Laura, Terracciano Luigi, Sahli Roland, Fraga Montserrat, Aepli Patrick, Hürlimann Sandra, Neuweiler Jörg, Semela David, Kreutzer Susanne, Honcharova-Biletska Hanna, Bawohl Marion, Malehmir Mohsen, Gouttenoire Jérôme, Weber Achim
A systematic review and meta-analysis of HCV clearance
Gauthiez E, Moradpour D, Mullhaupt B, Negro F, Semela D, Semmo N, Villard J, Bibert S, Bochud P, Malinverni R, Heim M, Habfast-Robertson I, Rüeger S, Kutalik Z, Aubert V, Berg T, Cerny A, Gorgievski M, George J, Swiss Hepatitis C Cohort Study. A systematic review and meta-analysis of HCV clearance. Liver Int 2017; 37:1431-1445.
30.03.2017A systematic review and meta-analysis of HCV clearance
30.03.2017Liver Int 2017; 37:1431-1445
Gauthiez Emeline, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Semela David, Semmo Nasser, Villard Jean, Bibert Stéphanie, Bochud Pierre-Yves, Malinverni Raffaele, Heim Markus H, Habfast-Robertson Ines, Rüeger Sina, Kutalik Zoltán, Aubert Vincent, Berg Thomas, Cerny Andreas, Gorgievski Meri, George Jacob, Swiss Hepatitis C Cohort Study